Monday, December 8, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Kforce Shares Face Headwinds as Analysts Lower Targets

Robert Sasse by Robert Sasse
September 4, 2025
in Analysis, Dividends, MDAX & SDAX
0
Kforce Stock
0
SHARES
209
VIEWS
Share on FacebookShare on Twitter

Kforce Inc. is navigating a challenging market environment characterized by downward revisions in analyst price targets and persistent softness in staffing sector demand. Despite these pressures, the firm maintains its commitment to a consistent dividend policy, providing a key point of stability for its shareholders.

Quarterly Results Present a Mixed Picture

The company’s Q2 2025 financial performance revealed a complex scenario. Revenue reached $334.3 million, representing a sequential increase of 1.3% but a year-over-year decline of 6.2%. Earnings per share (EPS) came in at $0.59, slightly below the consensus expectation of $0.60.

Looking ahead, management issued Q3 guidance projecting revenue in the range of $324 million to $332 million. EPS is forecast to be between $0.53 and $0.61, indicating a continuation of the current cautious outlook.

Wall Street Sentiment Shifts

Market experts have adopted a more pessimistic stance. Truist Financial revised its price target downward from $50 to $46, while UBS Group made a more significant cut from $45 to $40. The current average price target sits at $52.33, with a wide range spanning from $40 to $71. The overall consensus rating for the stock remains at “Hold.”

Dividend Commitment Offers Stability

A central element of Kforce’s investor proposition remains its reliable dividend. The company declared a quarterly distribution of $0.39 per share, payable on September 26 to shareholders of record as of September 12.

Should investors sell immediately? Or is it worth buying Kforce?

  • Quarterly Dividend: $0.39 per share
  • Ex-Dividend Date: September 12, 2025
  • Payment Date: September 26, 2025
  • Annualized Dividend: $1.56
  • Dividend Yield: ~4.8%

A payout ratio of 65.27% is viewed as solid, underscoring the sustainability of these distributions even during periods of market volatility.

Technical and Fundamental Position

The stock is currently trading between $32.10 and $32.60, positioned well below its key moving averages. The 50-day moving average stands at $38.30, and the 200-day average is at $42.47. The 52-week high of $66.30 remains a distant point of comparison.

With a market capitalization of approximately $607 million and a P/E ratio of 12.18, the stock’s beta of 0.75 suggests it has been less volatile than the broader market. Institutional activity has been mixed; Magnetar Financial increased its stake, while Trefis issued an “Unattractive” rating, citing concerns over weak operational performance.

The focus now shifts to upcoming investor conferences scheduled for September 17 and 24. Management’s ability to articulate a convincing strategy for recovery will be critical, as the staffing industry faces continued headwinds and a near-term rebound is far from certain.

Ad

Kforce Stock: Buy or Sell?! New Kforce Analysis from December 8 delivers the answer:

The latest Kforce figures speak for themselves: Urgent action needed for Kforce investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 8.

Kforce: Buy or sell? Read more here...

Tags: Kforce
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

BioNTech Stock
Analysis

BioNTech’s Oncology Ambitions Gain Momentum with Promising Trial Data

December 8, 2025
Opendoor Stock
Analysis

Opendoor Shares Face Pressure Following Index Removal

December 8, 2025
Universal Logistics Stock
Analysis

Navigating Trade Policy Shifts: Implications for Universal Logistics

December 8, 2025
Next Post
Poseida Therapeutics Stock

Roche Completes Landmark Acquisition of Biotech Innovator Poseida Therapeutics

National Healthcare Stock

National Healthcare Shares Face Pivotal Technical Battle

Pet Acquisition LLC Stock

Petco Shares Plummet Amid Escalating Class Action Pressure

Recommended

ON Semiconductor Stock

Chip Sector Reels as Trade Tensions Spark Selloff

2 months ago
Gogo Stock

Gogo’s 5G Aviation Network Gains Momentum Amid Strong Quarterly Performance

1 month ago
Viking Therapeutics Stock

Viking Therapeutics Shares Dip as Pfizer Chooses Rival Acquisition

3 months ago
Tech-banking-finance

Anticipating Willdan Groups Quarterly Earnings Report What to Expect and How it Could Impact Stock Prices

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Main Capital Receives Bullish Initiation with Significant Price Target Upside

First Bank’s Q3 Results: A Tale of Robust Profits Amidst Revenue Shortfall

OMV’s Romanian Operations Stabilize After Brief Power Plant Shutdown

Barrick Gold Considers Major Corporate Restructuring to Unlock Value

A New Challenge Emerges for ASML’s Semiconductor Dominance

Blue-Chip Index Stalls as IBM Acquisition Weighs on Sentiment

Trending

BioNTech Stock
Analysis

BioNTech’s Oncology Ambitions Gain Momentum with Promising Trial Data

by Felix Baarz
December 8, 2025
0

For investors in BioNTech, the company's long-stated pivot beyond its COVID-19 vaccine foundation has awaited concrete validation....

Opendoor Stock

Opendoor Shares Face Pressure Following Index Removal

December 8, 2025
Universal Logistics Stock

Navigating Trade Policy Shifts: Implications for Universal Logistics

December 8, 2025
Main Capital Stock

Main Capital Receives Bullish Initiation with Significant Price Target Upside

December 8, 2025
First Bank Stock

First Bank’s Q3 Results: A Tale of Robust Profits Amidst Revenue Shortfall

December 8, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNTech’s Oncology Ambitions Gain Momentum with Promising Trial Data
  • Opendoor Shares Face Pressure Following Index Removal
  • Navigating Trade Policy Shifts: Implications for Universal Logistics

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com